CIK 0001377121 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Net income (USD) | -66.2 M | -77.2 M | ||
| Diluted EPS (USD/shares) | -2.05 | -2.6 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-02 | 4 | OWNERSHIP DOCUMENT | 2026-09-30 |
| 2026-09-30 | 144 | 144 | |
| 2026-09-10 | 4 | OWNERSHIP DOCUMENT | 2026-09-08 |
| 2026-09-08 | 4 | OWNERSHIP DOCUMENT | 2026-09-03 |
| 2026-08-13 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-12 | 4 | OWNERSHIP DOCUMENT | 2026-08-10 |
| 2026-08-10 | 144 | 144 | |
| 2026-08-07 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-05 | S-8 POS | S-8 POS | |
| 2026-08-05 | S-8 POS | S-8 POS | |
| 2026-08-05 | S-8 POS | S-8 POS | |
| 2026-08-05 | S-8 POS | S-8 POS | |
| 2026-08-05 | S-8 POS | S-8 POS | |
| 2026-08-05 | S-8 POS | S-8 POS | |
| 2026-08-05 | S-8 POS | S-8 POS | |
| 2026-08-05 | S-8 POS | S-8 POS | |
| 2026-08-05 | S-8 POS | S-8 POS | |
| 2026-08-05 | S-8 POS | S-8 POS | |
| 2026-08-05 | S-8 POS | S-8 POS | |
| 2026-08-05 | S-8 | FORM S-8 | |
| 2026-08-05 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-05 | 8-K | FORM 8-K items 2.02,7.01,9.01 | 2026-08-05 |
| 2026-06-25 | 4 | OWNERSHIP DOCUMENT | 2026-06-23 |
| 2026-06-23 | 144 | 144 | |
| 2026-06-18 | 8-K | FORM 8-K items 5.02,5.07,9.01 | 2026-06-17 |
Forms on file (last 1,000): 4 262, 8-K 105, SC 13G/A 60, 144 50, 10-Q 31, SC 13G 27, 3 25, S-8 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=PTGX (0.002 USD), /gw/filings/filings?ticker=PTGX&form=8-K, /gw/filings/facts?ticker=PTGX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange